X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Novartis Fact Sheet, Novartis Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Novartis Fact Sheet   (NVRT)

Here is the latest financial fact sheet of Novartis. For more details, see the Novartis quarterly results and Novartis share price and chart. For a sector overview, read our pharmaceuticals sector report.

NOVARTIS Price History

Price Rs 697.7
Mkt Cap Rs m 234,050
Vol '000 3.0
P/E X 398.7
P/CF X 289.3
EPS (TTM) Rs 1.8
% ch % 1.6
No. of shares m 335.46
% ch week % -0.8
% ch 1-mth % 5.6
% ch 12-mth % 15.6
52 week H/L Rs 980.0/590.0
(As on Mar 19, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

NOVARTIS Financials

No. of Mths
Year Ending
12
Mar-14
12
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
5-Yr Chart
Click to enlarge
NOVARTIS EQUITY SHARE DATA
High Rs605760982855758 
Low Rs361438556666579 
Sales per share (Unadj.) Rs269.8273.3215.8219.0228.4 
Earnings per share (Unadj.) Rs30.824.862.019.131.7 
Diluted earnings per shareRs2.92.45.91.72.3 
Cash flow per share (Unadj.) Rs32.026.063.120.332.8 
Dividends per share (Unadj.) Rs10.0010.0010.0010.0010.00 
Adj. dividends per shareRs0.950.950.950.890.74 
Dividend yield (eoy) %2.11.71.31.31.5 
Book value per share (Unadj.) Rs300.8313.5373.5307.0297.1 
Adj. book value per shareRs28.729.935.627.421.9 
Shares outstanding (eoy) m31.9631.9631.9629.9624.69 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x1.82.23.63.52.9 
Avg P/E ratio x15.724.212.439.821.1 
P/CF ratio (eoy) x15.123.012.237.520.4 
Price / Book Value ratio x1.61.92.12.52.2 
Dividend payout %32.440.416.152.431.5 
Avg Mkt Cap Rs m15,43319,14724,58022,77916,505 
No. of employees `0001.31.20.80.70.7 
Total wages/salary Rs m1,7422,0001,5671,3931,445 
Avg. sales/employee Rs Th6,663.37,236.09,172.59,736.28,441.3 
Avg. wages/employee Rs Th1,346.11,657.22,083.22,066.82,163.6 
Avg. net profit/employee Rs Th761.4655.42,636.8849.01,173.1 
NOVARTIS INCOME DATA
Net Sales Rs m8,6228,7346,8986,5625,639 
Other income Rs m9511,0768097021,718 
Total revenues Rs m9,5749,8107,7077,2647,357 
Gross profit Rs m-13-39-113259-63 
Depreciation Rs m3740353625 
Interest Rs m322755 
Profit before tax Rs m8999966599171,575 
Minority Interest Rs m00000 
Prior Period Items Rs m3961651700 
Extraordinary Inc (Exp) Rs m0-631,69600 
Tax Rs m310306389345792 
Profit after tax Rs m9857911,983572784 
Gross profit margin %-0.2-0.4-1.63.9-1.1 
Effective tax rate %34.530.759.037.650.3 
Net profit margin %11.49.128.78.713.9 
NOVARTIS BALANCE SHEET DATA
Current assets Rs m10,61010,63412,6379,7319,522 
Current liabilities Rs m2,1222,1072,0451,8303,296 
Net working cap to sales %98.597.6153.6120.4110.4 
Current ratio x5.05.06.25.32.9 
Inventory Days Days4442384937 
Debtors Days Days3335272328 
Net fixed assets Rs m7985695746 
Share capital Rs m160160160141123 
"Free" reserves Rs m9,4529,85911,7769,0567,213 
Net worth Rs m9,61410,02011,9369,1967,336 
Long term debt Rs m00000 
Total assets Rs m12,02112,46114,32611,49911,105 
Interest coverage x334.0475.1314.7128.429.5 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.70.50.60.5 
Return on assets %8.26.413.95.07.6 
Return on equity %10.27.916.66.210.7 
Return on capital %13.511.019.910.122.2 
Exports to sales %0.90.90.900 
Imports to sales %21.814.221.800 
Exports (fob) Rs m79806000 
Imports (cif) Rs m1,8771,2441,50300 
Fx inflow Rs m14414918612961 
Fx outflow Rs m2,3351,6451,8211,7343,630 
Net fx Rs m-2,191-1,497-1,635-1,605-3,570 
NOVARTIS CASH FLOW
From Operations Rs m -46 -596 566 -408 1,610 
From Investments Rs m 222 7,189 -6,305 4,236 687 
From Financial Activity Rs m -378 -377 -386 -3,318 -2,677 
Net Cashflow Rs m -202 6,217 -6,125 510 -380 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 75.0%
Indian inst/Mut Fund 2.0%
FIIs 1.6%
ADR/GDR 0.0%
Free float 21.5%
Shareholders 41,647
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Sandoz House, Shivsagar Estate, Dr. Annie Besant Road, Mumbai-18
E-MAIL girish.tekchandani@novartis.com WEB www.novartis.in
TELEPHONE (022) 2495 8400 FAX (022) 2495 0221
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Sharepro Serv., 13 AB, Samhita Warehousing, Andheri (E), Mumbai-72
AUDITOR Lovelock and Lewes
CHM: C. Snook COMP SEC: Girish Tekchandani YEAR OF INC: 1947 BSE CODE: 500672 FV (Rs): 5 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  SUVEN LIFESCIENCES  DISHMAN PHARMA  ALEMBIC LTD  

Compare NOVARTIS With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  SUVEN LIFESCIENCES  DISHMAN PHARMA  ALEMBIC LTD  

Compare NOVARTIS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Momentum; Sensex Ends 268 Points Higher(Closing)

After opening the day marginally higher, Indian share markets continued their momentum and ended their day on a positive note.

Views on news

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

Smallcaps Are Rallying and You Need to Make the Most of It Now(Profit Hunter)

Mar 7, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

The One Sector to Bet on Today as India Grows into a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Mar 7, 2019

India's defence sector is suddenly under the spotlight. Can this sector ride along India's long-term growth story?

Is it the Right Time to Buy Mid and Small Caps Now?(The 5 Minute Wrapup)

Mar 6, 2019

Mid and Small Caps have underperformed large caps in the past year. Is the tide about to turn?

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS - GSK PHARMA COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS